About TuHURA Biosciences, Inc.
http://www.tuhurabio.comTuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company is headquartered in Tampa, FL.
CEO
James A. Bianco
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2024-10-18 | Reverse | 1:35 |
| 2022-11-14 | Reverse | 1:50 |
ETFs Holding This Stock
Summary
Showing Top 3 of 38
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades
Grade Summary
Showing Top 2 of 2
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:2.27M
Value:$1.72M
BLACKROCK, INC.
Shares:1.52M
Value:$1.15M
GEODE CAPITAL MANAGEMENT, LLC
Shares:622.77K
Value:$471.31K
Summary
Showing Top 3 of 71
About TuHURA Biosciences, Inc.
http://www.tuhurabio.comTuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company is headquartered in Tampa, FL.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 | $23.62M ▲ | $-23.3M ▼ | 0% | $0 ▲ | $0 ▲ |
| Q2-2025 | $0 | $9.88M ▲ | $-9.52M ▼ | 0% | $-0.21 ▼ | $-9.52M ▼ |
| Q4-2024 | $0 | $5.68M ▲ | $-6M ▼ | 0% | $-0.14 ▲ | $-5.46M ▼ |
| Q3-2024 | $0 | $2.21M ▲ | $-5.58K ▼ | 0% | $-3 ▼ | $-2.18M ▼ |
| Q2-2024 | $0 | $0 | $0 | 0% | $-1.47 | $0 |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2025 | $8.51M ▼ | $34.62M ▲ | $15.17M ▲ | $19.45M ▲ |
| Q4-2024 | $12.66M ▲ | $19.97M ▲ | $5.37M ▲ | $14.59M ▲ |
| Q3-2024 | $3.02M ▼ | $4.14M ▼ | $2.44M | $1.7M ▼ |
| Q2-2024 | $4.91M ▲ | $6.2M ▲ | $2.44M ▼ | $3.76M ▲ |
| Q1-2024 | $4.46M | $5.79M | $11.85M | $-6.07M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2025 | $-16.19M ▼ | $-10.99M ▼ | $-1.31M ▼ | $8.15M ▲ | $-4.14M ▼ | $-11.03M ▼ |
| Q4-2024 | $-6M ▼ | $-2.6M ▼ | $-823.54K ▼ | $-3.52M ▼ | $0 ▲ | $-2.62M ▼ |
| Q3-2024 | $-2.16M ▲ | $-1.89M ▲ | $0 | $0 ▼ | $-1.89M ▼ | $-1.89M ▲ |
| Q1-2024 | $-4.84M ▼ | $-3.83M ▼ | $0 ▲ | $4.63M ▲ | $796.46K ▲ | $-3.83M ▼ |
| Q4-2023 | $-1.02M | $-2.12M | $-20K | $2.58M | $0 | $-2.14M |
CEO
James A. Bianco
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2024-10-18 | Reverse | 1:35 |
| 2022-11-14 | Reverse | 1:50 |
ETFs Holding This Stock
Summary
Showing Top 3 of 38
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades
Grade Summary
Showing Top 2 of 2
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:2.27M
Value:$1.72M
BLACKROCK, INC.
Shares:1.52M
Value:$1.15M
GEODE CAPITAL MANAGEMENT, LLC
Shares:622.77K
Value:$471.31K
Summary
Showing Top 3 of 71